Allogeneic Mesenchymal Stem Cells

BIOLOGICAL4 trials

Sponsors

Stempeutics Research Pvt Ltd, Anterogen Co., Ltd., Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

Conditions

Alcoholic Liver CirrhosisBuerger's DiseaseCritical Limb IschemiaDystrophic Epidermolysis BullosaUrinary Incontinence Stress

Phase 1

Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa

CompletedNCT02579369

Anterogen Co., Ltd.Dystrophic Epidermolysis Bullosa

Start: 2015-12-08End: 2023-04-30Updated: 2023-08-25

Allogeneic Use of Expanded Mesenchymal Stem Cells Derived From Adipose Tissue (HC106), Female Urinary Incontinence Women Over 50 Years Old

RecruitingNCT06738576

Instituto de Investigación Sanitaria de la Fundación Jiménez DíazUrinary Incontinence Stress

Start: 2024-12-16End: 2025-12-31Target: 60Updated: 2025-05-01

Phase 2

A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease

CompletedNCT01484574

Stempeutics Research Pvt LtdBuerger's Disease, Critical Limb Ischemia

Start: 2012-01-31End: 2016-03-31Updated: 2016-09-13

Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis

CompletedNCT01591200

Stempeutics Research Pvt LtdAlcoholic Liver Cirrhosis

Start: 2012-06-30End: 2016-04-30Updated: 2016-09-15